Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 10, 2011

View Archived Issues

Ortho-McNeil-Janssen discloses new gamma-secretase modulators

Tempero Pharmaceuticals presents novel histone deacetylase 9 inhibitors

Apricus seeks approval in Latin America for topical erectile dysfunction drug

New lysophospholipid S1P1 receptor agonists claimed

Stiefel submits NDA for tazarotene foam

Johns Hopkins receives NIH funding for 5-year research project

Pseudotyped VLP-based vaccines show promise against hepatitis C

Sanofi discovers novel CaMK-II subunit delta inhibitors

CR-845 advances in new phase II trial in postoperative pain

Intercept Pharmaceuticals and Servier enter diabetes collaboration

FDA approves generic levetiracetam injection

Scientists to assess biomarkers in ProTECT trial participants

Arena Pharmaceuticals and Eisai report on lorcaserin carcinogenicity study

Meridian Bioscience launches new rapid test for CDI in Europe

Quidel molecular RT-PCR assay obtains CE mark approval

U.S. Department of Defense contracts Neuralstem to develop brain tumor therapy

Helsinn Therapeutics begins ROMANA 1 and 2 trials in NSCLC-related cachexia

MMV identifies new antimalarial aminopyridine derivatives

Stellar Biotech and Sigma-Aldrich collaborate for keyhole limpet hemocyanin

NanoViricides provides pipeline update and plans first IND submission

DelMar Pharmaceuticals receives Canada Industrial Research Assistance Program funding

New radioimmunotherapy enters phase I evaluation in HER2-positive intra-abdominal cancers

Histone deacetylase 6 inhibitor reverses symptoms of Charcot-Marie-Tooth disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...